Jpmorgan Chase & CO Procept Bio Robotics Corp Put Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$453 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$326 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$144 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$116 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$110 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.17B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...